156 related articles for article (PubMed ID: 12070149)
1. Peritoneal CD5+ B-1 cells have signaling properties similar to tolerant B cells.
Wong SC; Chew WK; Tan JE; Melendez AJ; Francis F; Lam KP
J Biol Chem; 2002 Aug; 277(34):30707-15. PubMed ID: 12070149
[TBL] [Abstract][Full Text] [Related]
2. The B lymphocyte adaptor molecule of 32 kD (Bam32) regulates B cell antigen receptor signaling and cell survival.
Niiro H; Maeda A; Kurosaki T; Clark EA
J Exp Med; 2002 Jan; 195(1):143-9. PubMed ID: 11781373
[TBL] [Abstract][Full Text] [Related]
3. B cell receptor directs the activation of NFAT and NF-kappaB via distinct molecular mechanisms.
Antony P; Petro JB; Carlesso G; Shinners NP; Lowe J; Khan WN
Exp Cell Res; 2003 Nov; 291(1):11-24. PubMed ID: 14597404
[TBL] [Abstract][Full Text] [Related]
4. Activation of extracellular signal-regulated kinase through B-cell antigen receptor in B-cell chronic lymphocytic leukemia.
Kawauchi K; Ogasawara T; Yasuyama M
Int J Hematol; 2002 Jun; 75(5):508-13. PubMed ID: 12095152
[TBL] [Abstract][Full Text] [Related]
5. The adaptor protein BLNK is required for b cell antigen receptor-induced activation of nuclear factor-kappa B and cell cycle entry and survival of B lymphocytes.
Tan JE; Wong SC; Gan SK; Xu S; Lam KP
J Biol Chem; 2001 Jun; 276(23):20055-63. PubMed ID: 11274146
[TBL] [Abstract][Full Text] [Related]
6. Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells.
Petlickovski A; Laurenti L; Li X; Marietti S; Chiusolo P; Sica S; Leone G; Efremov DG
Blood; 2005 Jun; 105(12):4820-7. PubMed ID: 15728130
[TBL] [Abstract][Full Text] [Related]
7. B-cell receptor- and phorbol ester-induced NF-kappaB and c-Jun N-terminal kinase activation in B cells requires novel protein kinase C's.
Krappmann D; Patke A; Heissmeyer V; Scheidereit C
Mol Cell Biol; 2001 Oct; 21(19):6640-50. PubMed ID: 11533251
[TBL] [Abstract][Full Text] [Related]
8. p38 MAPK is required for CD40-induced gene expression and proliferation in B lymphocytes.
Craxton A; Shu G; Graves JD; Saklatvala J; Krebs EG; Clark EA
J Immunol; 1998 Oct; 161(7):3225-36. PubMed ID: 9759836
[TBL] [Abstract][Full Text] [Related]
9. B cell receptor (BCR) cross-talk: CD40 engagement creates an alternate pathway for BCR signaling that activates I kappa B kinase/I kappa B alpha/NF-kappa B without the need for PI3K and phospholipase C gamma.
Mizuno T; Rothstein TL
J Immunol; 2005 May; 174(10):6062-70. PubMed ID: 15879100
[TBL] [Abstract][Full Text] [Related]
10. Antigen-receptor cross-linking and lipopolysaccharide trigger distinct phosphoinositide 3-kinase-dependent pathways to NF-kappa B activation in primary B cells.
Bone H; Williams NA
Int Immunol; 2001 Jun; 13(6):807-16. PubMed ID: 11369709
[TBL] [Abstract][Full Text] [Related]
11. Different nuclear signals are activated by the B cell receptor during positive versus negative signaling.
Healy JI; Dolmetsch RE; Timmerman LA; Cyster JG; Thomas ML; Crabtree GR; Lewis RS; Goodnow CC
Immunity; 1997 Apr; 6(4):419-28. PubMed ID: 9133421
[TBL] [Abstract][Full Text] [Related]
12. Positive signaling through CD72 induces mitogen-activated protein kinase activation and synergizes with B cell receptor signals to induce X-linked immunodeficiency B cell proliferation.
Wu HJ; Venkataraman C; Estus S; Dong C; Davis RJ; Flavell RA; Bondada S
J Immunol; 2001 Aug; 167(3):1263-73. PubMed ID: 11466342
[TBL] [Abstract][Full Text] [Related]
13. Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38.
Madrid LV; Mayo MW; Reuther JY; Baldwin AS
J Biol Chem; 2001 Jun; 276(22):18934-40. PubMed ID: 11259436
[TBL] [Abstract][Full Text] [Related]
14. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.
Takada Y; Ichikawa H; Pataer A; Swisher S; Aggarwal BB
Oncogene; 2007 Feb; 26(8):1201-12. PubMed ID: 16924232
[TBL] [Abstract][Full Text] [Related]
15. 8p12 stem cell myeloproliferative disorder: the FOP-fibroblast growth factor receptor 1 fusion protein of the t(6;8) translocation induces cell survival mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt/mTOR pathways.
Guasch G; Ollendorff V; Borg JP; Birnbaum D; Pébusque MJ
Mol Cell Biol; 2001 Dec; 21(23):8129-42. PubMed ID: 11689702
[TBL] [Abstract][Full Text] [Related]
16. Genetic deletion of glycogen synthase kinase-3beta abrogates activation of IkappaBalpha kinase, JNK, Akt, and p44/p42 MAPK but potentiates apoptosis induced by tumor necrosis factor.
Takada Y; Fang X; Jamaluddin MS; Boyd DD; Aggarwal BB
J Biol Chem; 2004 Sep; 279(38):39541-54. PubMed ID: 15252041
[TBL] [Abstract][Full Text] [Related]
17. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
[TBL] [Abstract][Full Text] [Related]
18. Differential activation of the ERK, JNK, and p38 mitogen-activated protein kinases by CD40 and the B cell antigen receptor.
Sutherland CL; Heath AW; Pelech SL; Young PR; Gold MR
J Immunol; 1996 Oct; 157(8):3381-90. PubMed ID: 8871635
[TBL] [Abstract][Full Text] [Related]
19. Tpl-2 induces IL-2 expression in T-cell lines by triggering multiple signaling pathways that activate NFAT and NF-kappaB.
Tsatsanis C; Patriotis C; Tsichlis PN
Oncogene; 1998 Nov; 17(20):2609-18. PubMed ID: 9840924
[TBL] [Abstract][Full Text] [Related]
20. Quantitative and qualitative control of antigen receptor signalling in tolerant B lymphocytes.
Healy JI; Dolmetsch RE; Lewis RS; Goodnow CC
Novartis Found Symp; 1998; 215():137-44; discussion 144-5, 186-90. PubMed ID: 9760576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
